Cambridge Medixine Ltd.
CamMed is developing a novel AI-powered RNA platform technology to create safer, faster, and more effective vaccines and therapeutics. Their mission is to overcome biological and technological constraints to deliver more accessible healthcare by enabling previously unsuccessful therapeutics, advancing therapeutic development timelines, and reducing drug manufacturing costs. The company has received recognition as a Deep Tech Pioneer by Hello Tomorrow and has been accepted into the KQ Labs Accelerator Program, securing a £40k investment.
Cambridge Medixine Ltd.
CamMed is developing a novel AI-powered RNA platform technology to create safer, faster, and more effective vaccines and therapeutics. Their mission is to overcome biological and technological constraints to deliver more accessible healthcare by enabling previously unsuccessful therapeutics, advancing therapeutic development timelines, and reducing drug manufacturing costs. The company has received recognition as a Deep Tech Pioneer by Hello Tomorrow and has been accepted into the KQ Labs Accelerator Program, securing a £40k investment.